Role of Site-Specific Glycosylation in the I-Like Domain of Integrin β1 in Small Extracellular Vesicle-Mediated Malignant Behavior and FAK Activation

Lin Cao,Yurong Wu,Xiuxiu Wang,Xiang Li,Zengqi Tan,Feng Guan

DOI: https://doi.org/10.3390/ijms22041770

IF: 5.6

2021-02-10

International Journal of Molecular Sciences

Abstract:Integrin β1 plays an essential role in the crosstalk between tumor cells and their microenvironment. Aberrant N-glycosylation of integrin β1 was documented to alter integrin β1 expression, dimerization, and biological function. However, the biological function of site-specific N-glycosylation of integrin β1 on extracellular vesicles is not fully understood. In this study, we mutated putative N-glycosylation sites in different domains of integrin β1. Removal of the N-glycosylation sites on the I-like domain of integrin β1 (termed the Δ4–6 β1 mutant) suppressed focal adhesion kinase (FAK) signaling, cell migration, and adhesion compared with other β1 mutants. Cell adhesion, migration, and activation of FAK were suppressed in recipient MCF7 cells co-cultured with Δ4–6 mutant cells and treated with small extracellular vesicles (sEVs) from Δ4–6 mutant cells. Notably, the wild-type and β1 mutant were both present in sEVs, and could be transferred to recipient cells via sEVs, resulting in changes of cell behavior. Our findings demonstrate the important roles of N-glycosylation of the I-like domain of integrin β1. Moreover, the vesicular Δ4–6 β1 mutant can regulate integrin-mediated functions in recipient cells via sEVs.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper aims to investigate the role of Integrin β1 in small extracellular vesicles (sEVs)-mediated malignant behavior and FAK signaling activation, particularly the impact of N-glycosylation at specific sites within its I-like domain on its function.

By constructing different mutants of Integrin β1, the paper explores the effects of removing N-glycosylation at various sites on cell adhesion, migration, and FAK signaling pathway activation. The results indicate that removing N-glycosylation sites in the I-like domain (referred to as ∆4–6 mutants) significantly inhibits cell adhesion and migration and weakens the activation of the FAK signaling pathway. Additionally, the study finds that when these mutants are delivered to recipient cells via sEVs, they can affect the behavior of the recipient cells, including adhesion ability, migration ability, and apoptosis. Notably, sEVs containing I-like domain N-glycosylation mutants significantly inhibit the migration ability of recipient cells but do not affect their proliferation ability.

In summary, the paper addresses the following key issues:
1. N-glycosylation at specific sites is crucial for the function of Integrin β1, especially in regulating cell adhesion and migration.
2. N-glycosylation in the I-like domain is important for the function of Integrin β1 when delivered to recipient cells via sEVs.